{"title":"Regional epidemiologic data call for enhanced attention to Clostridioides difficile infections in Italy: Results from a population-based study","authors":"Fabrizio Stracci , Camilla Gobbetti , Gaia Baccarini , Chiara Lupi , Antonella Mencacci , Gabrio Bassotti , Pierfrancesco Marconi , Katia Fettucciari , Silvia Leite , Alessio Gili , CLOS working group","doi":"10.1016/j.jiph.2025.102928","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><em>Clostridioides difficile (C. difficile</em>) Infection (CDI) is a major public health concern, causing a range of gastrointestinal diseases with increasing global incidence. In Italy, epidemiologic data on <em>Clostridioides difficile</em> CDI, particularly on community-acquired cases, are limited. This study aimed to provide population-based incidence data for CDI in Umbria, Italy, from 2014 to 2022, analyzing trends, demographics, recurrence rates, and 30-day all-cause mortality.</div></div><div><h3>Methods</h3><div>We used laboratory data from all regional public hospitals and local health units. CDI cases were <em>C. difficile</em> strains growing in culture and with toxin genes. The presence of toxin genes was confirmed by Xpert <em>C. difficile</em> Binary Toxin testing. Cases were categorized into hospital-acquired (HA-CDI) or community-acquired (CA-CDI). Incidence rates per 100,000 inhabitants per year were calculated. We analyzed incidence and 30-day mortality trends over a nine-year period. Logistic regression assessed predictors of 30-day mortality.</div></div><div><h3>Results</h3><div>5955 CDI cases were identified (57.7 % female). Overall incidence increased from 48.1 cases per 100,000 inhabitants in 2014–88 cases in 2022 (CA-CDI rose from 25.2 to 39 and HA-CDI from 22.9 to 49.2). The 30-day mortality risk was 17.6 % (1045 deaths). In multivariable analysis, adjusted 30-day all-cause mortality risk was higher among HA-CDI patients compared to CA-CDI (OR 1.8, 95 % CI 1.6–2.1). 30-day mortality risk was also higher for elderly patients and male gender. Moreover, the mortality risk was stable over time. Recurrence occurred in 655 (11 %) of patients.</div></div><div><h3>Conclusions</h3><div>The worrisome finding of increasing incidence of CDI in all settings, including hospital, indicates the urgency of establishing a stable surveillance system for CDIs. Considering the unfavorable trend and high mortality, measures to reduce the risk of CDI would be indicated, particularly in hospital and elderly home care settings where vulnerable patients concentrate.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 11","pages":"Article 102928"},"PeriodicalIF":4.0000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125002771","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Clostridioides difficile (C. difficile) Infection (CDI) is a major public health concern, causing a range of gastrointestinal diseases with increasing global incidence. In Italy, epidemiologic data on Clostridioides difficile CDI, particularly on community-acquired cases, are limited. This study aimed to provide population-based incidence data for CDI in Umbria, Italy, from 2014 to 2022, analyzing trends, demographics, recurrence rates, and 30-day all-cause mortality.
Methods
We used laboratory data from all regional public hospitals and local health units. CDI cases were C. difficile strains growing in culture and with toxin genes. The presence of toxin genes was confirmed by Xpert C. difficile Binary Toxin testing. Cases were categorized into hospital-acquired (HA-CDI) or community-acquired (CA-CDI). Incidence rates per 100,000 inhabitants per year were calculated. We analyzed incidence and 30-day mortality trends over a nine-year period. Logistic regression assessed predictors of 30-day mortality.
Results
5955 CDI cases were identified (57.7 % female). Overall incidence increased from 48.1 cases per 100,000 inhabitants in 2014–88 cases in 2022 (CA-CDI rose from 25.2 to 39 and HA-CDI from 22.9 to 49.2). The 30-day mortality risk was 17.6 % (1045 deaths). In multivariable analysis, adjusted 30-day all-cause mortality risk was higher among HA-CDI patients compared to CA-CDI (OR 1.8, 95 % CI 1.6–2.1). 30-day mortality risk was also higher for elderly patients and male gender. Moreover, the mortality risk was stable over time. Recurrence occurred in 655 (11 %) of patients.
Conclusions
The worrisome finding of increasing incidence of CDI in all settings, including hospital, indicates the urgency of establishing a stable surveillance system for CDIs. Considering the unfavorable trend and high mortality, measures to reduce the risk of CDI would be indicated, particularly in hospital and elderly home care settings where vulnerable patients concentrate.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.